Check out these key findings about Denison Mines Corp (DNN)

With 19.14 million shares changed hands, the volume of the stock remained heavier than its average volume of 13.9 million shares. During the session, the Uranium company that operates in wider Energy sector, reached to the highest price of $2.0800 whereas the lowest price it dropped to was $1.9700. The 52-week range on DNN shows that it touched its highest point at $2.15 and its lowest point at $0.98 during that stretch. It currently has a 1-year price target of $2.99. Beta for the stock currently stands at 1.68.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of DNN was up-trending over the past week, with a rise of 6.70%, but this was up by 16.29% over a month. Three-month performance surged to 21.05% while six-month performance rose 18.29%. The stock gained 97.14% in the past year, while it has gained 16.95% so far this year. A look at the trailing 12-month EPS for DNN yields 0.04 with Next year EPS estimates of -0.02. For the next quarter, that number is -0.00. This implies an EPS growth rate of -118.32% for this year and -20.70% for next year.

Float and Shares Shorts:

At present, 890.97 million DNN shares are outstanding with a float of 877.79 million shares on hand for trading. On Mar 15, 2024, short shares totaled 42.34 million, which was 5.01% higher than short shares on Feb 15, 2024. In addition to DVN as the firm’s Devon Energy Corporation, DNA serves as its Ginkgo Bioworks Holdings, Inc.

Institutional Ownership:

Through their ownership of 49.80% of DNN’s outstanding shares, institutional investors have minority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for DNN since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.